Methes Energies International (MEIL) 10-Q 14 Jul 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	6 Months Ended
	31-May-14	Jul. 14, 2014
Document And Entity Information	'	'
Entity Registrant Name	'METHES ENERGIES INTERNATIONAL LTD	'
Entity Central Index Key	'0001436549	'
Document Type	'10-Q	'
Document Period End Date	31-May-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--11-30	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Public Float	'	$0
Entity Common Stock, Shares Outstanding	'	11,435,431
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	31-May-14	Nov. 30, 2013
Current assets	'	'
Cash and cash equivalents	$4,048,226	$174,084
Accounts receivable, net (notes 10 and 12)	136,637	1,154,916
Inventories (note 3)	249,728	801,063
Prepaid expenses and deposits	402,768	84,990
Deferred financing fees	6,424	49,139
Total current assets	4,843,783	2,264,192
Deposits	28,199	30,398
Property, plant and equipment, net (note 4)	8,056,626	8,178,694
Intangible assets, net	382,913	393,015
Total assets	13,311,521	10,866,300
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Credit facility (note 7)	0	1,019,513
Accounts payable (note 10)	1,740,695	2,766,661
Accrued liabilities	224,664	211,296
Customer deposits (note 10)	9,104	8,185
Payable to related parties and others (note 5)	745,750	2,251,402
Short-term loans (note 6)	3,394,039	1,961,651
Total liabilities	6,114,252	8,218,708
Stockholders' equity	'	'
Preferred stock, $0.001 par value, 10,000,000 shares authorized; 260,782 and 111,822 shares issued and outstanding as at November 30, 2013 and May 31, 2014, respectively (note 8)	112	261
Common stock, $0.001 par value, 75,000,000 shares authorized; 7,231,417 and 11,435,431 shares issued and outstanding at November 30, 2013 and May 31, 2014, respectively (note 8)	11,435	7,231
Additional paid-in capital	26,142,945	18,532,803
Accumulated deficit	-18,957,223	-15,892,703
Total stockholders' equity	7,197,269	2,647,592
Total liabilities and stockholders' equity	$13,311,521	$10,866,300

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	31-May-14	Nov. 30, 2013
Stockholders' equity	'	'
Preferred stock par value	$0.00	$0.00
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock shares issued	111,822	260,782
Preferred stock shares outstanding	111,822	260,782
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	11,435,431	7,231,417
Common stock, shares outstanding	11,435,431	7,231,417

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	31-May-14	31-May-13	31-May-14	31-May-13
Revenue	'	'	'	'
Biodiesel sales	$316,294	$2,080,304	$625,831	$2,210,740
Feedstock sales	69,719	40,802	96,341	84,988
Glycerin sales	10,649	22,635	23,847	36,441
Government incentives (note 12)	25,557	170,124	38,592	179,004
Equipment sales	750	2,657	1,397	2,657
Royalties	11,454	2,793	11,454	6,775
Others	4,982	9,039	20,421	17,860
Revenue, Total	439,405	2,328,354	817,883	2,538,465
Cost of goods sold	371,921	2,221,184	664,540	2,410,713
Gross profit	67,484	107,170	153,343	127,752
Operating expenses	'	'	'	'
Selling, general and administrative expenses (notes 4, 8 and 9)	1,442,291	1,476,838	2,907,700	2,767,926
Loss before interest and income taxes	-1,374,807	-1,369,668	-2,754,357	-2,640,174
Other (expenses)	'	'	'	'
Interest expense (notes 5, 6 and 7)	-192,035	-122,143	-293,927	-242,969
Loss before income taxes	-1,566,842	-1,491,811	-3,048,284	-2,883,143
Income taxes	0	0	0	0
Net loss for the period	($1,566,842)	($1,491,811)	($3,048,284)	($2,883,143)
Net Loss Per Common Share - Basic and Diluted	($0.18)	($0.21)	($0.36)	($0.42)
Weighted average number of common shares - Basic and Diluted	8,702,605	6,978,169	8,411,002	6,790,324

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	6 Months Ended
	31-May-14	31-May-13
Cash flow from operating activities:	'	'
Net loss for the period	($3,048,284)	($2,883,143)
Adjustments to reconcile net loss to net cash provided by (used in) operations	'	'
Depreciation and amortization	222,197	243,695
Stock-based compensation	95,749	66,633
Unrealized foreign exchange gain	-40,357	-76,193
Deferred financing fees amortization	42,715	22,583
Accrued interest	90,623	81,641
Bad debts	35,662	0
Issuance of common stock/units for consulting services	371,854	0
Changes in operating assets and liabilities:	'	'
Accounts receivable	982,617	-113,432
Inventories	551,335	97,173
Prepaid expenses and deposits	-240,184	-15,756
Accounts payable and accrued liabilities	-1,012,596	440,132
Customer deposits	919	0
Net cash used in operating activities	-1,947,750	-2,136,667
Cash flows from investing activities:	'	'
Additions to property, plant and equipment	-90,027	-351,828
Additions to intangible assets	0	-191
Net cash used in investing activities	-90,027	-352,019
Cash flows from financing activities:	'	'
Repayment of credit facility	-1,019,513	0
Advances from short-term loans	135,705	385,800
Repayments of short term loans	-269,401	0
Advances from related parties and others	172,000	519,258
Repayments to related parties and others	-33,835	0
Issuance of common stock/units under private placement (net of issuance costs)	6,812,963	1,369,390
Issuance of common stock/units for cash	100,000	0
Issuance of common stock upon conversion of placement agent warrants	14,000	0
Net cash provided by financing activities	5,911,919	2,274,448
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	3,874,142	-214,238
Cash and cash equivalents, beginning of period	174,084	402,724
CASH AND CASH EQUIVALENTS, END OF PERIOD	4,048,226	188,486
Supplemental disclosures of cash flow information, cash paid:	'	'
Interest paid	216,674	171,723
Common shares issued as repayment of loan	$128,000	$0

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (USD $)	Common Stock	Preferred Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Amount at Nov. 30, 2012	$6,553	'	$16,033,123	($10,241,029)	$5,798,647
Beginning Balance, Shares at Nov. 30, 2012	6,553,169	'	'	'	'
Issuance of units under private placement, Shares	653,248	'	'	'	'
Issuance of units under private placement, Amount	653	'	2,149,347	'	2,150,000
Issuance cost common stock units under private placement	'	'	-368,611	'	-368,611
Issuance of Common stock for services, Shares	25,000	'	'	'	'
Issuance of Common stock for services, Amount	25	'	51,975	'	52,000
Issuance of preferred stock units under private placements, Share	'	260,782	'	'	'
Issuance of preferred stock units under private placements, Amount	'	261	622,239	'	622,500
Issuance cost - preferred stock under private placement	'	'	-149,330	'	-149,330
Stock based compensation	'	'	155,578	'	155,578
Dividends payable on preferred stock units	'	'	'	-9	-9
Issuance of common stock options to employees and officer	'	'	38,482	'	38,482
Net loss for the period	'	'	'	-5,651,665	-5,651,665
Ending Balance, Amount at Nov. 30, 2013	7,231	261	18,532,803	-15,892,703	2,647,592
Ending Balance, Shares at Nov. 30, 2013	7,231,417	260,782	'	'	'
Issuance of units under private placement, Shares	1,081,161	'	'	'	'
Issuance of units under private placement, Amount	1,081	'	2,161,240	'	2,162,321
Issuance of common stock under public offering, Shares	2,800,000	'	'	'	'
Issuance of common stock under public offering, Amount	2,800	'	5,597,200	'	5,600,000
Issuance cost common stock units under private placement	'	'	-949,358	'	-949,358
Issuance of common stock units for cash, Shares	16,129	'	'	'	'
Issuance of common stock units for cash, Amount	16	'	99,984	'	100,000
Issuance of common stock units for cash upon conversion of preferred stock units, Shares	148,960	-148,960	'	'	'
Issuance of common stock units for cash upon conversion of preferred stock units, Amount	149	-149	'	'	'
Issuance of common stock upon conversion of dividends on preferred stock, Shares	7,205	'	'	'	'
Issuance of common stock upon conversion of dividends on preferred stock, Amount	7	'	16,229	-16,236	'
Issuance of Common stock for services, Shares	108,871	'	'	'	'
Issuance of Common stock for services, Amount	109	'	447,141	'	447,250
Issuance of common stock units for loan settlement, Shares	34,688	'	'	'	'
Issuance of common stock units for loan settlement, Amount	35	'	127,964	'	128,000
Issuance of common stock upon conversion of placement agent warrants, Shares	7,000	'	'	'	'
Issuance of common stock upon conversion of placement agent warrants, Amount	7	'	13,993	'	14,000
Stock based compensation	'	'	95,749	'	95,749
Net loss for the period	'	'	'	-3,048,284	-3,048,284
Ending Balance, Amount at May. 31, 2014	$11,435	$112	$26,142,945	($18,957,223)	$7,197,269
Ending Balance, Shares at May. 31, 2014	11,435,431	111,822	'	'	'

1_NATURE_OF_THE_BUSINESS_FINAN

1. NATURE OF THE BUSINESS, FINANCING REQUIREMENTS AND BASIS OF PRESENTATION	6 Months Ended
	31-May-14
Accounting Policies [Abstract]	'
1. NATURE OF THE BUSINESS, FINANCING REQUIREMENTS AND BASIS OF PRESENTATION	'
	Methes Energies International Ltd. ("Methes" or the "Company"), was incorporated on June 27, 2007 in the State of Nevada. Methes, through its operations in Canada and the United States, is a biodiesel processing equipment provider and a biodiesel producer. The Company has developed biodiesel processing equipment to produce biodiesel from recycled oils. The Company, through its wholly-owned subsidiary Methes Energies Canada Inc. ("Methes Canada"), operates two biodiesel manufacturing facilities; one is located in Mississauga, Ontario with a nameplate production capacity of 1.3 million gallons per year (mgy), and the second facility is capable of producing 13.0 mgy of biodiesel located in Sombra, Ontario. In addition to Methes Canada, Methes Energies USA Ltd. ("Methes USA") was incorporated as the wholly-owned subsidiary of the Company on June 27, 2007. All references in this Form 10-Q to “Company,” “Methes,” “we,” “us,” or “our” refer to Methes Energies International Ltd. and its wholly owned subsidiaries Methes Canada and Methes USA unless the context otherwise indicates.
	As at May 31, 2014, due in large part to the funds spent to develop, build and commission our Sombra facility as well as minimal sales of biodiesel, the Company had a working capital deficiency of $1,270,469. During the six months ended May 31, 2014, the Company incurred a loss of $3,048,284 and had negative cash flows from operations of $1,947,750. The Company anticipates that its Sombra facility will generate positive cash flows from operations and will operate profitably once full-scale commercial operations are achieved in the second half of fiscal year 2014. However, in order to meet its development goals and ongoing operational requirements, the Company will require additional financing in the foreseeable future. It is management’s opinion that the anticipated positive cash flows from operations and cash from additional financing completed in May 2014 will be sufficient to meet the Company’s cash requirements for at least the next 12 months.
	The condensed consolidated financial statements have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted as permitted by such rules and regulations. All adjustments, consisting of normal recurring adjustments, have been included. Management believes that the disclosures are adequate to present fairly the financial position, results of operations and cash flows at the dates and for the periods presented. It is suggested that these interim financial statements be read in conjunction with the consolidated financial statements and the notes thereto appearing in the Company’s latest annual report on Form 10-K. Results for interim periods are not necessarily indicative of those to be expected for the full fiscal year.

2_SUMMARY_OF_SIGNIFICANT_ACCOU

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	31-May-14
Accounting Policies [Abstract]	'
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	Basis of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Methes Canada and Methes USA.  All significant inter-company transactions and balances have been eliminated.
	Deferred Financing Fees
	Financing fees relating to other financing arrangements are deferred and amortized over the term of the respective loan.
	Shipping and Handling Costs
	The Company accounts for shipping and handling fees in accordance with FASB ASC 705 "Cost of Sales and Services". Shipping and handling costs for the three and six months ended May 31, 2014 were $8,032 and $23,602, respectively (three and six months ended May 31, 2013 was $101,561 and $175,255, respectively). Costs related to raw materials purchased, are included in inventory or cost of goods sold, as appropriate. While amounts charged to customers for shipping product are included in revenues, the related outbound freight costs are included in expenses as incurred.
	Income Taxes and Uncertain Tax Positions
	The Company accounts for income taxes under ASC 740 Accounting for Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. ASC 740-10-05, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.
	For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
	The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Potential tax benefits from net operating losses and foreign tax credit carry forwards are not recognized by the Company until their realization is more likely than not. The Company assesses the validity of conclusions regarding uncertain tax positions on a quarterly basis to determine if facts or circumstances have arisen that might cause the Company to change their judgment regarding the likelihood of a tax position's sustainability under audit. The Company has determined that there were no material uncertain tax positions as at November 30, 2013 and May 31, 2014.
	Per Share Data
	Basic earnings per share ("EPS") is determined by dividing net earnings available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. In computing diluted EPS, the average number of shares of Common Stock outstanding is increased by Common Stock options and warrants outstanding if the exercise prices were lower than the average market price of Common Stocks using the treasury stock method. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. Potentially dilutive shares include 2,163,764 warrants and 483,310 Common Stock options issued and outstanding as at May 31, 2013 and 3,923,149 warrants, 353,922 Common Stock options and 111,822 shares of Preferred Stock issued and outstanding as at May 31, 2014. All outstanding warrants, preferred shares and options have an anti-dilutive effect on the loss per share and are therefore excluded from the determination of the diluted loss per share calculation for the three and six months ended May 31, 2013 and May 31, 2014.
	New Accounting Pronouncements
	In December 2011, the FASB issued ASU No. 2011-11, Disclosures about Offsetting Assets and Liabilities (Topic 210). The new disclosure requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In addition, the standard requires disclosure of collateral received and posted in connection with master netting agreements or similar arrangements. The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The disclosures required by the amendments are required to be applied retrospectively for all comparative periods presented. The Company adopted this statement effective December 1, 2013. The adoption of this statement did not have a material effect on the Company’s unaudited condensed consolidated financial statements.
	On May 28, 2014, the FASB issued a new financial accounting standard on revenue from contracts with customers, Update No. 2014-09, Revenue from Contracts with Customers (Topic 606). The standard outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance. The accounting standard is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. Early adoption is not permitted. The Company is currently evaluating the impact of this accounting standard.
	All other recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the condensed consolidated financial statements of the Company.

3_INVENTORIES

3. INVENTORIES	6 Months Ended
	31-May-14
Inventory Disclosure [Abstract]	'
3. INVENTORIES	'
	Inventories consisted of the following:
		As at		As at
		November 30,		May 31,
		2013		2014
	Raw materials	$	345,049	$	148,748
	Finished goods		444,648		89,614
	Equipment		11,366		11,366
		$	801,063	$	249,728

4_PROPERTY_PLANT_AND_EQUIPMENT

4. PROPERTY, PLANT AND EQUIPMENT	6 Months Ended
	31-May-14
Property, Plant and Equipment [Abstract]	'
4. PROPERTY, PLANT AND EQUIPMENT	'
		As at May 31, 2014						As at
								November 30,
								2013
		Cost		Accumulated		Net Book		Net Book
				Depreciation		Value		Value
	Sombra site:
	Land	$	409,134	$	—	$	409,134	$	409,134
	Building		2,944,356		278,713		2,665,643		2,702,446
	Equipment		775,865		439,032		336,833		390,465
	Equipment - Denami 3000		4,254,995		273,939		3,981,056		3,975,441
	Computer equipment		11,835		8,827		3,008		5,918
	Vehicle		11,622		872		10,750		11,331
	Mississauga site:
	Computer equipment		23,464		22,985		479		1,316
	Leasehold improvements		102,201		60,805		41,396		46,591
	Equipment and fixtures		255,463		191,125		64,338		77,662
	Equipment - Denami 600		720,042		176,053		543,989		558,390
		$	9,508,977	$	1,452,351	$	8,056,626	$	8,178,694
	Total depreciation expense included in selling, general and administrative expenses in the unaudited consolidated statements of operations related to property, plant and equipment for the three and six months ended May 31, 2014 was $106,317 and $212,095, respectively (three and six months ended May 31, 2013 was $117,177 and $233,593, respectively).

5_PAYABLE_TO_RELATED_PARTIES

5. PAYABLE TO RELATED PARTIES	6 Months Ended
	31-May-14
Related Party Transactions [Abstract]	'
5. PAYABLE TO RELATED PARTIES	'
	Payable to related parties is comprised of the following:
		As at		As at
		November 30,		May 31,
		2013		2014
	Michel G. Laporte (stockholder and Director)	$	719,230	$	745,750
	World Asset Management Inc. (reclassified to short-term loans - Note 6, Promissory note (iii))		1,495,477		—
	Other loan		36,695		—
		$	2,251,402	$	745,750
	The payables to related parties and others bear interest at 8% per annum, are unsecured and repayable on demand.  The related parties and others have agreed in writing to postpone the repayment of their debts in favor of the credit facility referred to in note 7. Interest expense incurred during the three and six months ended May 31, 2014 was $13,260 and $26,250 (three and six months ended May 31, 2013 - $28,465 and $60,625).

6_SHORTTERM_LOANS

6. SHORT-TERM LOANS	6 Months Ended
	31-May-14
Debt Disclosure [Abstract]	'
6. SHORT TERM LOAN	'
		As at		Advances and Reclassification		Interest Accrued		Repayments		Foreign Exchange Adjustments		As at
		November 30,										May 31,
		2013										2014
	Term loan (July 2013)	$	1,506,560	$	—	$	—	$	—	$	-30,880	$	1,475,680
	Term loan (Dec 2013)		—		135,705		2,506		—		2,640		140,851
	Promissory note (i)		52,533		—		1,600		—		—		54,133
	Promissory note (ii)		402,558		—		4,099		-397,400		-9,257		—
	Promissory note (iii)		—		1,667,477		55,898		—		—		1,723,375
		$	1,961,651	$	1,803,182	$	60,004	$	-429,971	$	-827	$	3,394,039
	Term loan (July 2013)
	On July 12, 2013, Methes Canada entered into a term loan facility agreement with a lender (the “Agreement”) pursuant to which Methes Canada is able to borrow up to $1,475,680  (historical amount of $1,540,640 or CDN$1,600,000) for a term of 12 months at an interest rate of 12% per annum (the “July 2013 Facility”). Under the terms of the Agreement, interest is payable monthly and outstanding principal is due at maturity. Outstanding principal would be prepayable after six months upon 30 days’ notice and payment of a penalty equal to one-month's interest. The July 2013 Facility is collateralized by a security agreement from Methes Canada on certain of its assets except for accounts receivable and inventory and a first collateral mortgage on its real property located at Sombra, Ontario.  The July 2013 Facility prohibits payment of debt owed by the Company to certain of its stockholders and a director (see note 5) during the life of the facility and contains other customary debt covenants. As at May 31, 2014, the Company was in compliance with these covenants.
	Interest expense incurred during the three and six months ended May 31, 2014 was $43,850 and $87,568 (three and six months ended May 31, 2013 - $nil and $nil).
	Term loan (December 2013)
	On December 16, 2013, Methes Canada entered into a one year term Mortgage Loan Agreement for $1,844,600 (CDN$2,000,000) bearing interest at 9% per annum for the purposes of discharging the existing July 2013 Facility (CDN$1,600,000).  The difference will be used to upgrade the Mississauga facility for the production of biodiesel.  Interest only is to be paid monthly and the term is renewable for an additional year.  As at May 31, 2014, monies advanced from this loan totaled $138,345 (historical amount of $135,705 or CDN$150,000).
	Interest expense incurred during the three and six months ended May 31, 2014 was $2,506 and $2,506 (three and six months ended May 31, 2013 - $nil and $nil).
	Promissory Notes:
	(i)	In January 2010, the Company borrowed $40,000 from a lender and issued to the lender a demand promissory note in the principal amount of $40,000 bearing interest at 8% per annum.  Repayment of the loan and payment of the accrued interest is due upon demand.
		Interest expense incurred during the three and six months ended May 31, 2014 was $800 and $1,600 (three and six months ended May 31, 2013 - $800 and $1,600).
	(ii)	On January 26, 2013, the Company borrowed $368,920 (historical amount of  $397,400 or  CDN $400,000) from a lender and issued to the lender a demand promissory note in the principal amount of CDN $400,000 bearing interest at 8% per annum (the "January 2013 Note"). Repayment of the loan and payment of the accrued interest is due upon demand.
		During the six months ended May 31, 2014 total principal payments of $397,400 (CDN$400,000) and total interest of $32,571 (CDN$34,057) were made against the note (now paid in full), as follows:
		- On January 17, 2014, the Company converted $128,000 USD (CDN $139,845) of the outstanding principal due on the January 2013 Note into 34,688 shares of Common Stock based at the closing market price of $3.69 per share of Common Stock on January 17, 2014.
		- On January 30, 2014, the Company paid $153,871 USD (CDN $172,000) against the outstanding principal balance through borrowing a note payable from another lender.
		- On May 30, 2014, the Company paid the remaining balance of $81,305 USD (CDN $88,155).
		Interest expense incurred during the three and six months ended May 31, 2014 was $1,569 and $4,099 (three and six months ended May 31, 2013 - $7,914 and $10,576).
	(iii)	Previously, this loan was classified as a payable to related party as the lender held stocks of the Company.  As at May 31, 2014, no stocks are held by the lender and therefore this loan has been re-classified under the short-term loans.  A total principal of $1,280,000 and accrued interest of $215,477 as at November 30, 2013 were reclassified to short-term loans.
		On January 28, 2014, the Company borrowed $172,000 from this lender and issued to the lender a demand promissory note in the principal amount of $172,000 bearing interest at 8% per annum.  Repayment of the loan and payment of the accrued interest is due upon demand.
		As at May 31, 2014, a total principal of $1,452,000 and accrued interest of $271,375 were outstanding. This loan bears interest at 8% per annum.  Repayment of the loan and payment of the accrued interest is due upon demand.
		Interest expense incurred during the three and six months ended May 31, 2014 was $29,040 and $55,898 (three and six months ended May 31, 2013 - $20,800 and $48,000).

7_CREDIT_FACILITY

7. CREDIT FACILITY	6 Months Ended
	31-May-14
Notes to Financial Statements	'
7. CREDIT FACILITY	'
	On August 16, 2013, Methes Canada entered into and closed on a working capital loan facility from a Toronto, Ontario lending firm (the “Working Capital Facility”). Under the Working Capital Facility, Methes Canada may borrow up to $1,500,000 for its Sombra, Ontario biodiesel manufacturing plant, of which up to $750,000 may be from cash advances against Methes Canada’s accounts receivables through factoring of accounts receivable with full recourse and up to an additional $750,000 in cash advances for use exclusively to purchase feedstock for the production of biodiesel. The Working Capital Facility is secured by a pledge of the accounts receivable and inventory of Methes Canada and Methes USA.
	In connection with all borrowings to purchase feedstock, Methes Canada issued a promissory note to the lender bearing a per annum interest rate equal to the Bank of Montreal Prime Rate plus sixteen percent (16%) and is due and payable upon the earlier of demand or August 13, 2014. The effective interest rate as of May 31, 2014 was 19% (16% plus 3% prime rate).  Under the terms of the promissory note, interest only is payable monthly on the last business day of each calendar month.
	Cash advances against accounts receivables will be based on the amount of the receivables net of a purchase discount as agreed with the lender with an interest rate of Bank of Montreal Prime Rate plus three percent (3%).  Effective interest rate as of May 31, 2014 was 6% (3% plus 3% prime rate). The amounts outstanding under this promissory note must be recorded on the grid schedule provided by the lender. The balance outstanding as at November 30, 2013 of $1,019,513 was fully repaid during the first quarter of fiscal 2014 through factoring of accounts receivable and cash from operations. Accordingly, as of May 31, 2014 the balance outstanding was $nil.
	Interest expense incurred under this credit facility during the three and six months ended May 31, 2014 was $nil and $7,909 (three and six months ended May 31, 2013 - $nil and $nil).
	Subsequent to the current quarter, the credit facility was discontinued (see Note 14).

8_STOCKHOLDERS_EQUITY

8. STOCKHOLDERS' EQUITY	6 Months Ended
	31-May-14
Equity [Abstract]	'
8. STOCKHOLDERS' EQUITY	'
	COMMON STOCK
	The Company is authorized to issue 75,000,000 shares of Common Stock with a par value of $0.001 and had 7,231,417 and 11,435,431 shares of Common Stock issued and outstanding as of November 30, 2013 and May 31, 2014, respectively.
			No. of Shares			Price per Share
	Common Stock
	Balance as at November 30, 2013			7,231,417
	December 2013 Private Placement			1,081,161		$	2
	January 3, 2014 Issuance for services rendered			25,000		$	3.49
	January 10, 2014 Issuance for cash and services rendered			50,000		$	2.5
	January 17, 2014 Issuance for loan settlement			34,688		$	3.69
	January 28, 2014 Issuance for services rendered			25,000		$	3.55
	March 13, 2014 Series A-2 Preferred Stock conversions			21,648		$	2.27
	March 17, 2014 Series A-1 Preferred Stock conversions and accrued dividends			123,528		$	2.25
	May 1, 2014 Issuance for services rendered			25,000		$	2.45
	May 9, 2014 Series A-2 Preferred Stock conversion			10,989		$	2.27
	May 9 and 19, 2014 Placement Agent Warrant exercises			7,000		$	2
	May 27, 2014 Underwritten public offering issuance			2,500,000		$	2
	May 28, 2014 Underwritten public offering over-allotment issuance			300,000		$	2
	Balance as at May 31, 2014			11,435,431
	December 2013 Private Placement
	During the month of December 2013 the Company issued a total of 1,081,161 units (each a “Unit”) to accredited investors at a price of $2.00 per Unit under a private placement and raised net proceeds of approximately $1.87 million, after deducting the sales commission and fees (the “December 2013 Private Placement”). Each Unit consists of one share of Common Stock and one five year Common Stock Warrant to purchase one share of Common Stock at an exercise price of $4.00 per share (“Common Stock Warrant”). (see Stock Warrant Table below).
	In connection with the December 2013 Private Placement, the Company issued compensatory warrants (the “Placement Agent Warrant”) to the Placement Agents for the offering exercisable for an aggregate of 108,116 Units.  Each of these warrants is exercisable to acquire a Unit at an exercise price of $2.00 per Unit.  The fair value of these warrants at the grant date was $257,553.  This amount was estimated using the Black-Scholes option pricing model with an expected life of 5 years, risk free interest rates between 1.66% and 1.74%, a dividend yield of 0%, and an expected volatility of 75%. (see Stock Warrant Table below).
	January 3, 2014 Issuance for services rendered
	On January 3, 2014, the Company issued 25,000 shares of Common Stock in the second installment quarterly payment of consulting fees for services to be rendered by a consultant which were valued at $87,250, based on the closing market price of $3.49 per share on the day of issuance.
	January 10, 2014 Issuance for cash and services rendered
	On January 10, 2014, the Company sold 50,000 Units to an accredited investor in a private placement for a purchase price of $125,000 (or $2.50 per Unit) of which $100,000 was paid in cash and $25,000 was settled through services rendered to the Company, which was included in the selling, general and administrative expenses. The aggregate fair value of the Units sold in this offering was $310,000 (or $6.20 per Unit), based on the closing market price of $3.58 per share of Common Stock on the day of issuance, and the fair value of the Common Stock Warrants of $2.62 per warrant.  The fair value of the Common Stock Warrants was estimated using the Black-Scholes option pricing model with an expected life of 5 years, risk free interest rates of 1.64%, a dividend yield of 0%, and an expected volatility of 100%.  The excess of the estimated fair value over the purchase price in the amount of $185,000 is included in the selling, general and administrative expenses. (see Stock Warrant Table below).
	January 17, 2014 Issuance for loan payment
	On January 17, 2014, the Company issued 34,688 shares of Common Stock to a note holder at $3.69 per share of Common Stock in conversion of $128,000 of a note payable by the Company (See Note 6, Promissory - (ii)).
	January 28, 2014 Issuance for services rendered
	On January 28, 2014, the Company issued 25,000 shares of Common Stock in payment of consulting fees for services to be rendered by a consulting corporation for a term of one year.  These shares of Common Stock were valued at $88,750, based on the closing market price of $3.55 per share on the date of issuance, of which $29,583 is included in prepaid expenses as at May 31, 2014.
	March 13, 2014 Series A-2 Preferred Stock Conversions
	On March 13, 2014, two holders of our Series A-2 Convertible Preferred Stock (“Series A-2 Preferred”) converted 20,876 shares of outstanding Series A-2 Preferred with an aggregate stated value of approximately $49,139 (including accrued dividends of $1,750) into 21,648 shares of Common Stock at a price of $2.27 per share.
	March 17, 2014 Series A-1 Preferred Stock Conversions
	On March 17, 2014, two holders of our Series A-1 Convertible Preferred Stock (“Series A-1 Preferred”) converted 117,646 shares of outstanding Series A-1 Preferred with an aggregate stated value of approximately $293,235 (including accrued dividends of $13,235) into 123,528 shares of Common Stock at a price of $2.25 per share.
	May 1, 2014 Issuance for services rendered
	On May 1, 2014, the Company issued 25,000 shares of Common Stock in the third quarterly installment payment of consulting fees for services to be rendered by a consultant which were valued at $61,250, based on the closing market price of $2.45 per share on the date of issuance, of which $45,813 is included in prepaid expenses as at May 31, 2014.
	May 9, 2014 Series A-2 Preferred Stock Conversion
	On May 9, 2014, a holder of our Series A-2 Preferred converted 10,438 shares of outstanding Series A-2 Preferred with an aggregate stated value of approximately $26,250 (including accrued dividends of $1,250) into 10,989 shares of Common Stock at a price of $2.27 per share.
	May 9 and 19, 2014 Placement Agent Warrants Exercises
	On May 9 and 19, 2014, two holders of Placement Agent Warrants exercised their warrants for an aggregate of 7,000 Units at a price of $2.00 per Unit or an aggregate stated value of $14,000, which included 7,000 shares of Common Stock and 7,000 Warrants (each an exercise price of $4.00).
	May 27, 2014 Underwritten Public Offering Issuance
	On May 27, 2014, the Company closed an underwritten public offering of 2,500,000 shares of Common Stock and raised net proceeds of $4.5 million, after deducting Underwriter’s fees and estimated offering expenses. Under the terms of the Underwriting Agreement, the Underwriter had an option through June 26, 2014, to purchase up to an additional 375,000 shares of Common Stock under the same terms as the public offering to cover over-allotments (the “Over-Allotment Option”), if any.
	May 28, 2014 Underwritten Public Offering Over Allotment Issuance
	On May 28, 2014, the Underwriter partially exercised the Over-Allotment Option for 300,000 shares of Common Stock raising approximately $550,000 of additional net proceeds for the Company.
	PREFERRED STOCK
	The Company is also authorized to issue up to 10,000,000 shares of preferred stock with a par value of $0.001 per share, from time to time in one or more series, without shareholder approval, when authorized by its board of directors (the “Board”).  As of each of November 30, 2013 and May 31, 2014, the Board has designated 152,519 shares of Series A-1 Preferred and 134,341 shares of Series A-2 Preferred.  As of November 30, 2013, 138,654 shares of Series A-1 Preferred and 122,128 shares of Series A-2 Preferred were issued and outstanding (for a total of 260,782 shares outstanding as of November 30, 2013).  During the six months ended May 31, 2014, 117,646 shares of Series A-1 Preferred and 31,314 shares of Series A-2 Preferred were converted into shares of Common Stock.  As of May 31, 2014, 21,008 shares of Series A-1 Preferred and 90,314 shares of Series A-2 Preferred were issued and outstanding (for a total of 111,822 shares outstanding as of May 31, 2014).  Collectively, the Series A-1 Preferred and the Series A-2 Preferred are referred to herein as the “Series A Preferred Stock.”
	As at May 31, 2014, on the Series A Preferred Stock had total accumulated dividends of $16,668, none of which have been declared by the Board or accrued (May 31, 2013 - $nil).
	STOCK WARRANT TABLE:
		Grant Date		Exercise Period	No of Warrants			Exercise Price per share		Fair Value of Broker Warrants
	Balance as at November 30, 2013					2,678,872
	Common Stock Warrants issued – Private Placement	Dec. 20, 2013		5 years from grant date		1,081,161		$	4
	Placement Agent Warrant – Private Placement	Dec. 20 2013		5 years from grant date		108,116		$	2	$	257,553
	Placement Agent Warrant – Private Placement (November 27, 2013)	Dec. 20 2013		5 years from grant date		5,000		$	2	$	6,403
	Common Stock Warrant issued-accredited investor	Jan. 10, 2014		5 years from grant date		50,000		$	4
	Placement Agent Warrant exercise					-7,000		$	2
	Common Stock Warrant issued upon exercise of Placement Agent Warrant	May 9 and 14, 2014				7,000		$	4
				Dec. 20, 2018
	Balance as at May 31, 2014					3,923,149

9_STOCKBASED_COMPENSATION

9. STOCK-BASED COMPENSATION	6 Months Ended
	31-May-14
Equity [Abstract]	'
9. STOCK-BASED COMPENSATION	'
	The Company's Amended and Restated the 2008 Directors, Officers and Employees Stock Option Plan, which was originally approved by the stockholders at the annual general meeting of the Company held on December 5, 2007, and subsequently amended by the stockholders on July 23, 2008. This plan was established to enable the Company to attract and retain the services of highly qualified and experienced directors, officers, employees and consultants and to give such persons an interest in the success of the Company and its subsidiaries. The total number of shares currently authorized under the plan is 391,134. The options and awards will be granted at the discretion of the Board of Directors. Options issued under the plan that are deemed to be incentive stock options will be priced at not less than 100% of the fair market value of the common shares at the date of the grant, subject to certain limitations for 10 percent stockholders. The fair value of each option granted was estimated at the time of grant using the Black-Scholes option pricing model. There were no options granted during the six months ended May 31, 2013 and 2014.
	All the grants vest quarterly over a two year period and expire on the tenth anniversary of the grant date. The following table summarizes the stock option activities of the Company.
		Number of options
	Outstanding as of November 30, 2012		383,310
	Granted		10,000
	Exercised		—
	Cancelled/forfeited		-27,379
	Outstanding as of November 30, 2013		365,931
	Granted		—
	Exercised		—
	Cancelled/forfeited		-5,215
	Outstanding as of May 31, 2014		360,716
	The stock-based compensation for the three and six months ended May 31, 2014 was $2,824 and $7,696 (six months ended May 31, 2013 - $28,150 and $66,632). The Company recorded this in selling, general and administrative expenses with the corresponding credit to additional paid-in capital.
	As of November 30, 2013 the Company has a total of 365,931 options outstanding to purchase Common Stock held by employees, directors and advisory board members, of which 353,922 are vested and exercisable. All of these outstanding stock options have an exercise price above the average market price. As of November 30, 2013, the total fair value of the options granted to employees at the respective grant dates was $1,476,973, of which the unrecognized portion of $13,088 related to the unvested shares associated with these stock option grants will be recognized over a period of two years.
	As of May 31, 2014 the Company has a total of 360,716 options outstanding to purchase Common Stock held by employees, directors and advisory board members, of which 354,466 are vested and exercisable. All of these outstanding stock options have an exercise price above the average market price. As of May 31, 2014, the total fair value of the options granted to employees at the respective grant dates was $1,476,973, of which the unrecognized portion of $5,392 related to the unvested shares associated with these stock option grants will be recognized over a period of 18 months.
	2012 Option Plan:
	Under the Company’s 2012 Directors, Officers and Employees Stock Option Plan (the “2012 Plan”), the Company granted a total of 100,000 options to purchase Common Stock to its four independent directors and chief financial officer on April 2, 2013.  The total number of shares currently authorized under the plan is 400,000.  The options and awards will be granted at the discretion of the Board. Options issued under this plan that are deemed to be incentive stock options will be priced at not less than 100 percent of the fair market value of the shares of Common Stock underlying the options at the date of the grant, subject to certain limitations for 10 percent stockholders. The fair value of each option granted was estimated at the time of grant using the Black-Scholes option pricing model.
	All the options granted under the 2012 Plan, vest yearly at the rate of one-third per year, starting on the first year anniversary of the grant date and expire on the fifth anniversary of the grant date. The following table summarizes the stock option activities of the Company.
	Outstanding as of November 30, 2012		—
	Granted		100,000
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of November 30, 2013		100,000
	Granted		—
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of May 31, 2014		100,000
	The share-based compensation for the three and six months ended May 31, 2014 was $44,026 and $88,052 (three and six months ended May 31, 2013 - $nil and $nil). The Company recorded this in selling, general and administrative expenses with the corresponding credit to additional paid-in capital.
	As of November 30, 2013 the Company has granted options to purchase a total of 100,000 shares of Common Stock at an exercise price of $3.94 per share, to its four independent directors and chief financial officer, all of which are currently outstanding and of which none are vested and exercisable. All of these outstanding stock options have an exercise price equal to the fair market price on the date of grant. As of November 30, 2013, the total fair value of the options granted to the independent directors and chief financial officer at the respective grant dates was $292,174, of which the unrecognized portion of $186,022 related to the unvested shares associated with these stock option grants will be recognized over a period of three years.
	As of May 31, 2014 the Company has granted a total of 100,000 options to purchase Common Stock to employees, directors and advisory board members, all of which are currently outstanding and of which none are vested and exercisable. All of these outstanding stock options have an exercise price above the average market price. As of May 31, 2014, the total fair value of the options granted at the respective grant dates was $292,174, of which the unrecognized portion of $97,970 related to the unvested shares associated with these stock option grants will be recognized over a period of two years.

10_FAIR_VALUE_MEASUREMENTS_CON

10. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK	6 Months Ended
	31-May-14
Fair Value Disclosures [Abstract]	'
10. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK	'
	a) The Company's cash and cash equivalents, which are carried at fair values, are classified as a level 1 financial instrument at November 30, 2013 and May 31, 2014.
	b) The Company is exposed to the following concentrations of risk:
	Major Customers
	Two major customers comprised 66% and 68% of total revenue for the three and six months ended May 31, 2014 (three and six months ended May 31, 2013 - two major customers comprised 66% and 22% of total revenue).
	As at November 30, 2013, the accounts receivable balance from the two major customers was $659,902 and $26,083 respectively. As at May 31, 2014, the accounts receivable balance from two major customers was $Nil and $39,740 respectively.
	Major Vendors
	The Company has an exclusive agreement to manufacture biodiesel processor equipment with a third party equipment manufacturer. During the three and six months ended May 31, 2014, the Company made purchases of $nil and $nil (three and six months ended May 31, 2013 - $nil and $45,893) from this equipment manufacturer. As of November 30, 2013 and May 31, 2014, the Company had accounts payable of $21,856 and $6,837 owing to this equipment manufacturer, respectively.
	The Company’s major purchases of feedstock oil and biodiesel from third parties for the three and six months ended May 31, 2014 were $nil and $nil (three and six months ended May 31, 2013 – three major vendors comprising total purchases of $1,051,843 and $1,566,918).
	As at November 30, 2013, the accounts payable balance to the three major vendors were $nil, $1,053,479 and $575,043.
	As at May 31, 2014, the accounts payable balance from the three major vendors was $1,046,453 (balance includes interest incurred on outstanding balance of $97,973), $nil and $352,670.  These balances were paid in full subsequent to quarter end.
	Economic and Political Risks
	The Company faces a number of risks and challenges as a result of having primary operations and marketing in Canada and sales in the United States.  Changing political climates in Canada and the United States could have a significant effect on the Company’s business.
	c) The Company's financial instruments are exposed to certain financial risks, including credit risk, currency risk and liquidity risk.
	Credit Risk
	Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations, and arises principally from the Company's cash and cash equivalents and trade accounts receivable. The Company places its cash and cash equivalents with institutions of high creditworthiness. The carrying value of the financial assets represents the maximum credit exposure.
	The Company minimizes credit risk by routinely reviewing the credit risk of the counterparty to the arrangement and has maintained an allowance for doubtful accounts of $65,662 related to credit risk as at May 31, 2014 (as at November 30, 2013 - $30,000), which is considered adequate.
	Currency Risk
	The Company is exposed to the financial risk related to the fluctuation of foreign exchange rates. The Company's functional currency is U.S. dollars. A significant change in the currency exchange rates between the U.S. dollar relative to the Canadian dollar could have an effect on the Company's results of operations, financial position and cash flows. The Company has not entered into any derivative financial instruments to manage exposures to currency fluctuations.
	Included in selling, general and administrative expenses are foreign currency gains (losses) for the three and six months ended May 31, 2014 of $49,576 and ($30,210) (three and six months ended May 31, 2013 of $1,579 and $75,959).
	Liquidity Risk
	Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company's normal operating requirements on an ongoing basis and its expansionary plans. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash.
	As at May 31, 2014, due in large part to the funds spent to develop and build the Sombra facility as well as minimal sales of biodiesel, the Company had a working capital deficiency of $1,270,469.
	The Company anticipates that its Sombra facility will generate positive cash flows from operations and will operate profitably once full-scale commercial operations are achieved in the second half of fiscal year 2014. It is management’s opinion that the anticipated positive cash flows from operations and cash from additional financing completed in May 2014 will be sufficient to meet the Company’s cash requirements for at least the next 12 months.
	As at May 31, 2014, the Company received customer deposits of $9,104 (November 30, 2013 - $8,185) against equipment to be shipped in the subsequent quarter.

11_COMMITMENTS

11. COMMITMENTS	6 Months Ended
	31-May-14
Commitments and Contingencies Disclosure [Abstract]	'
11. COMMITMENTS	'
	Building Leases:
	Methes Canada is a party to a lease agreement for the Mississauga facility and to a sublease agreement for a unit adjacent to its Mississauga facility. On September 28, 2012, the Company re-negotiated and renewed a combined five year lease term for both of these facilities starting from January 1, 2013 to December 31, 2017. The renewed lease term provides for a two month rent free period in 2013.
	As at May 31, 2014, Methes Canada must pay, in addition to other amounts such as it’s pro rata share of taxes, the following amounts over the term of the lease:
			Annual
			Minimum Rent
	2014		$	68,129
	2015		$	136,259
	2016		$	136,259
	2017		$	136,259
	2018		$	11,355
	Railroad Car Leases:
	As at May 31, 2014, the Company is a party to the following lease agreements for railcars at its Sombra facility:
		Start Date		End Date	Term
	Four railcars at $3,100 per month	1-Aug-13		31-Jul-18	60 months
	Four railcars at $3,100 per month	1-Apr-13		31-Mar-18	60 months
	Four railcars at $ 3,600 per month	1-Jul-13		30-Jun-18	60 months
	Four railcars at $3,140  per month	1-Dec-11		30-Nov-16	60 months
	One railcar at $575 per month	1-Jan-12		31-Dec-16	60 months
	One railcar at $575 per month	1-May-12		30-Jun-15	36 months
	Ten railcars at $8,460 per month	1-May-13		30-Apr-18	60 months
	Ten railcars at $8,510 per month	1-May-13		30-Apr-18	60 months
			Annual
			Minimum Rent
	2014		$	186,360
	2015		$	369,845
	2016		$	365,820
	2017		$	321,815
	2018		$	147,250

12_CONTRIBUTION_AGREEMENTS_WIT

12. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA	6 Months Ended
	31-May-14
Notes to Financial Statements	'
12. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA	'
	Mississauga Facility:
	In 2009, the Company entered into a Non-Refundable Contribution Agreement with the Minister of Natural Resources of Canada for the Mississauga facility under the ecoENERGY for Biofuels program. Under this agreement, the Company may receive up to $4,989,643 (CDN$5,410,000) in the years from 2009 to 2016 from the Canadian government in biodiesel production incentives when biodiesel is produced and sold. The contribution from the Canadian Government is non-refundable by the Company.
	For the three and six months ended May 31, 2014, the Company claimed incentives of $nil and $nil (three and six months ended May 31, 2013 - $8,559 and $10,170). Since entering into the program to May 31, 2014, the Company has claimed total incentives of $1,485,285 and has received a total of $1,458,286.
	Included in accounts receivable as at November 30, 2013 and May 31, 2014, is an amount receivable of $nil and $nil, respectively, due from the Minister of Natural Resources of Canada.
	Sombra Facility:
	In 2010, the Company applied for an incentive under the ecoENERGY for Biofuels program for its Sombra facility and was approved by the Canadian government. The final Contribution Agreement with the Minister of Natural Resources of Canada for the Sombra facility under the ecoENERGY for Biofuels program was signed by the Company and the Canadian Government on December 6, 2011. Under this agreement as amended, the Company may receive up to $13,636,390 (CDN$14,785,200) from the years 2012 to 2017 from the Canadian government in biodiesel production incentives when biodiesel is produced and sold. The contribution from the Canadian Government is non-refundable by the Company.
	For the three and six months ended May 31, 2014, the Company claimed incentives of $25,557 and $38,592 (three and six months ended May 31, 2013 - $161,565 and $168,833). Since entering into the program to May 31, 2014, the Company has claimed total incentives of $575,467 and has received a total of $549,910.
	Included in accounts receivable as at November 30, 2013 and May 31, 2014, is an amount receivable of $277,573 and $25,557, respectively, due from the Minister of Natural Resources of Canada.

13_SEGMENT_INFORMATION

13. SEGMENT INFORMATION	6 Months Ended
	31-May-14
Segment Reporting [Abstract]	'
13. SEGMENT INFORMATION	'
	The Company reports a single operating segment, being a producer and seller of biodiesel fuel and biodiesel processing equipment.
	Geographic segments:
	The Company's assets and operating facilities, other than cash balances of $16,066 at November 30, 2013 and $822,978 at May 31, 2014, are all located in Canada. The Company services the majority of its customers in the United States. The Company derives its revenue geographically as follows:
		Three Months Ended May 31, 2013		Three Months Ended May 31, 2014		Six Months Ended		Six Months Ended
						May 31,		May 31,
						2013		2014
	Revenue
	United States	$	2,071,344	$	289,778	$	2,171,133	$	570,972
	Canada		257,010		149,627		367,332		246,911
		$	2,328,354	$	439,405	$	2,538,465	$	817,883

14_SUBSEQUENT_EVENTS

14. SUBSEQUENT EVENTS	6 Months Ended
	31-May-14
Subsequent Events [Abstract]	'
14. SUBSEQUENT EVENTS	'
	In June 2014, the Working Capital Facility of $1,500,000, described in Note 7 was discontinued, as the Company’s management believes it no longer requires this facility.
	In June 2014, the Company entered into certain derivative contracts to hedge its exposure to price risk related to feedstock oil.

2_SUMMARY_OF_SIGNIFICANT_ACCOU1

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	31-May-14
Accounting Policies [Abstract]	'
Basis of Consolidation	'
	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Methes Canada and Methes USA.  All significant inter-company transactions and balances have been eliminated.
Deferred Financing Fees	'
	Financing fees relating to other financing arrangements are deferred and amortized over the term of the respective loan.
Shipping and Handling Costs	'
	The Company accounts for shipping and handling fees in accordance with FASB ASC 705 "Cost of Sales and Services". Shipping and handling costs for the three and six months ended May 31, 2014 were $8,032 and $23,602, respectively (three and six months ended May 31, 2013 was $101,561 and $175,255, respectively). Costs related to raw materials purchased, are included in inventory or cost of goods sold, as appropriate. While amounts charged to customers for shipping product are included in revenues, the related outbound freight costs are included in expenses as incurred.
Income Taxes and Uncertain Tax Positions	'
	The Company accounts for income taxes under ASC 740 Accounting for Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. ASC 740-10-05, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.
	For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
	The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Potential tax benefits from net operating losses and foreign tax credit carry forwards are not recognized by the Company until their realization is more likely than not. The Company assesses the validity of conclusions regarding uncertain tax positions on a quarterly basis to determine if facts or circumstances have arisen that might cause the Company to change their judgment regarding the likelihood of a tax position's sustainability under audit. The Company has determined that there were no material uncertain tax positions as at November 30, 2013 and May 31, 2014.
Per Share Data	'
	Per Share Data
	Basic earnings per share ("EPS") is determined by dividing net earnings available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. In computing diluted EPS, the average number of shares of Common Stock outstanding is increased by Common Stock options and warrants outstanding if the exercise prices were lower than the average market price of Common Stocks using the treasury stock method. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. Potentially dilutive shares include 2,163,764 warrants and 483,310 Common Stock options issued and outstanding as at May 31, 2013 and 3,923,149 warrants, 353,922 Common Stock options and 111,822 shares of Preferred Stock issued and outstanding as at May 31, 2014. All outstanding warrants, preferred shares and options have an anti-dilutive effect on the loss per share and are therefore excluded from the determination of the diluted loss per share calculation for the three and six months ended May 31, 2013 and May 31, 2014.
New Accounting Pronouncements	'
	New Accounting Pronouncements
	In December 2011, the FASB issued ASU No. 2011-11, Disclosures about Offsetting Assets and Liabilities (Topic 210). The new disclosure requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In addition, the standard requires disclosure of collateral received and posted in connection with master netting agreements or similar arrangements. The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The disclosures required by the amendments are required to be applied retrospectively for all comparative periods presented. The Company adopted this statement effective December 1, 2013. The adoption of this statement did not have a material effect on the Company’s unaudited condensed consolidated financial statements.
	On May 28, 2014, the FASB issued a new financial accounting standard on revenue from contracts with customers, Update No. 2014-09, Revenue from Contracts with Customers (Topic 606). The standard outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance. The accounting standard is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. Early adoption is not permitted. The Company is currently evaluating the impact of this accounting standard.
	All other recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the condensed consolidated financial statements of the Company.

3_INVENTORIES_Tables

3. INVENTORIES (Tables)	6 Months Ended
	31-May-14
Inventory Disclosure [Abstract]	'
Schedule of Inventories	'
		As at		As at
		November 30,		May 31,
		2013		2014
	Raw materials	$	345,049	$	148,748
	Finished goods		444,648		89,614
	Equipment		11,366		11,366
		$	801,063	$	249,728

4_PROPERTY_PLANT_AND_EQUIPMENT1

4. PROPERTY, PLANT AND EQUIPMENT (Tables)	6 Months Ended
	31-May-14
Property, Plant and Equipment [Abstract]	'
Schedule of Property, Plant and Equipment	'
		As at May 31, 2014						As at
								November 30,
								2013
		Cost		Accumulated		Net Book		Net Book
				Depreciation		Value		Value
	Sombra site:
	Land	$	409,134	$	—	$	409,134	$	409,134
	Building		2,944,356		278,713		2,665,643		2,702,446
	Equipment		775,865		439,032		336,833		390,465
	Equipment - Denami 3000		4,254,995		273,939		3,981,056		3,975,441
	Computer equipment		11,835		8,827		3,008		5,918
	Vehicle		11,622		872		10,750		11,331
	Mississauga site:
	Computer equipment		23,464		22,985		479		1,316
	Leasehold improvements		102,201		60,805		41,396		46,591
	Equipment and fixtures		255,463		191,125		64,338		77,662
	Equipment - Denami 600		720,042		176,053		543,989		558,390
		$	9,508,977	$	1,452,351	$	8,056,626	$	8,178,694

5_PAYABLE_TO_RELATED_PARTIES_T

5. PAYABLE TO RELATED PARTIES (Tables)	6 Months Ended
	31-May-14
Related Party Transactions [Abstract]	'
Schedule of Payable to Related Parties	'
		As at		As at
		November 30,		May 31,
		2013		2014
	Michel G. Laporte (stockholder and Director)	$	719,230	$	745,750
	World Asset Management Inc. (reclassified to short-term loans - Note 6, Promissory note (iii))		1,495,477		—
	Other loan		36,695		—
		$	2,251,402	$	745,750

6_SHORTTERM_LOANS_Tables

6. SHORT-TERM LOANS (Tables)	6 Months Ended
	31-May-14
Short-Term Loans Tables	'
Short-term loans	'
		As at		Advances and Reclassification		Interest Accrued		Repayments		Foreign Exchange Adjustments		As at
		November 30,										May 31,
		2013										2014
	Term loan (July 2013)	$	1,506,560	$	—	$	—	$	—	$	-30,880	$	1,475,680
	Term loan (Dec 2013)		—		135,705		2,506		—		2,640		140,851
	Promissory note (i)		52,533		—		1,600		—		—		54,133
	Promissory note (ii)		402,558		—		4,099		-397,400		-9,257		—
	Promissory note (iii)		—		1,667,477		55,898		—		—		1,723,375
		$	1,961,651	$	1,803,182	$	60,004	$	-429,971	$	-827	$	3,394,039

8_STOCKHOLDERS_EQUITY_Tables

8. STOCKHOLDERS' EQUITY (Tables)	6 Months Ended
	31-May-14
Stockholders Equity Tables	'
Common stock	'
			No. of Shares			Price per Share
	Common Stock
	Balance as at November 30, 2013			7,231,417
	December 2013 Private Placement			1,081,161		$	2
	January 3, 2014 Issuance for services rendered			25,000		$	3.49
	January 10, 2014 Issuance for cash and services rendered			50,000		$	2.5
	January 17, 2014 Issuance for loan settlement			34,688		$	3.69
	January 28, 2014 Issuance for services rendered			25,000		$	3.55
	March 13, 2014 Series A-2 Preferred Stock conversions			21,648		$	2.27
	March 17, 2014 Series A-1 Preferred Stock conversions and accrued dividends			123,528		$	2.25
	May 1, 2014 Issuance for services rendered			25,000		$	2.45
	May 9, 2014 Series A-2 Preferred Stock conversion			10,989		$	2.27
	May 9 and 19, 2014 Placement Agent Warrant exercises			7,000		$	2
	May 27, 2014 Underwritten public offering issuance			2,500,000		$	2
	May 28, 2014 Underwritten public offering over-allotment issuance			300,000		$	2
	Balance as at May 31, 2014			11,435,431
Stock warrant table	'
		Grant Date		Exercise Period	No of Warrants			Exercise Price per share		Fair Value of Broker Warrants
	Balance as at November 30, 2013					2,678,872
	Common Stock Warrants issued – Private Placement	Dec. 20, 2013		5 years from grant date		1,081,161		$	4
	Placement Agent Warrant – Private Placement	Dec. 20 2013		5 years from grant date		108,116		$	2	$	257,553
	Placement Agent Warrant – Private Placement (November 27, 2013)	Dec. 20 2013		5 years from grant date		5,000		$	2	$	6,403
	Common Stock Warrant issued-accredited investor	Jan. 10, 2014		5 years from grant date		50,000		$	4
	Placement Agent Warrant exercise					-7,000		$	2
	Common Stock Warrant issued upon exercise of Placement Agent Warrant	May 9 and 14, 2014				7,000		$	4
				Dec. 20, 2018
	Balance as at May 31, 2014					3,923,149

9_STOCKBASED_COMPENSATION_Tabl

9. STOCK-BASED COMPENSATION (Tables)	6 Months Ended
	31-May-14
Stock option activities	'
		Number of options
	Outstanding as of November 30, 2012		383,310
	Granted		10,000
	Exercised		—
	Cancelled/forfeited		-27,379
	Outstanding as of November 30, 2013		365,931
	Granted		—
	Exercised		—
	Cancelled/forfeited		-5,215
	Outstanding as of May 31, 2014		360,716
2012 Option Plan	'
Stock option activities	'
	Outstanding as of November 30, 2012		—
	Granted		100,000
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of November 30, 2013		100,000
	Granted		—
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of May 31, 2014		100,000

11_COMMITMENTS_Tables

11. COMMITMENTS (Tables)	6 Months Ended
	31-May-14
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Annual Minimum Rent	'
			Annual
			Minimum Rent
	2014		$	68,129
	2015		$	136,259
	2016		$	136,259
	2017		$	136,259
	2018		$	11,355
Schedule of lease agreements	'
		Start Date		End Date	Term
	Four railcars at $3,100 per month	1-Aug-13		31-Jul-18	60 months
	Four railcars at $3,100 per month	1-Apr-13		31-Mar-18	60 months
	Four railcars at $ 3,600 per month	1-Jul-13		30-Jun-18	60 months
	Four railcars at $3,140  per month	1-Dec-11		30-Nov-16	60 months
	One railcar at $575 per month	1-Jan-12		31-Dec-16	60 months
	One railcar at $575 per month	1-May-12		30-Jun-15	36 months
	Ten railcars at $8,460 per month	1-May-13		30-Apr-18	60 months
	Ten railcars at $8,510 per month	1-May-13		30-Apr-18	60 months
Schedule of annual minimum rental payments	'
			Annual
			Minimum Rent
	2014		$	186,360
	2015		$	369,845
	2016		$	365,820
	2017		$	321,815
	2018		$	147,250

13_SEGMENT_INFORMATION_Tables

13. SEGMENT INFORMATION (Tables)	6 Months Ended
	31-May-14
Segment Reporting [Abstract]	'
Schedule of Revenue Geographically	'
		Three Months Ended May 31, 2013		Three Months Ended May 31, 2014		Six Months Ended		Six Months Ended
						May 31,		May 31,
						2013		2014
	Revenue
	United States	$	2,071,344	$	289,778	$	2,171,133	$	570,972
	Canada		257,010		149,627		367,332		246,911
		$	2,328,354	$	439,405	$	2,538,465	$	817,883

1_BASIS_OF_PRESENTATION_AND_NA

1. BASIS OF PRESENTATION AND NATURE OF THE BUSINESS (Details Narrative) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	31-May-14	31-May-13	31-May-14	31-May-13	Nov. 30, 2013
Basis Of Presentation And Nature Of Business Details Narrative	'	'	'	'	'
Working capital deficiency	$1,270,469	'	$1,270,469	'	'
Loss incurred	1,566,842	1,491,811	3,048,284	2,883,143	5,651,665
Net cash used in operating activities	'	'	($1,947,750)	($2,136,667)	'

2_SUMMARY_OF_SIGNIFICANT_ACCOU2

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)	3 Months Ended		6 Months Ended
	31-May-14	31-May-13	31-May-14	31-May-13
Shipping and handling costs	$8,032	$101,561	$23,602	$175,255
Preferred Stock	'	'	'	'
Anti-dilutive securities excluded from earnings calculations	'	'	111,822	'
Warrants	'	'	'	'
Anti-dilutive securities excluded from earnings calculations	'	'	3,923,149	2,163,764
Stock Options	'	'	'	'
Anti-dilutive securities excluded from earnings calculations	'	'	353,922	483,310

3_INVENTORIES_Details

3. INVENTORIES (Details) (USD $)	31-May-14	Nov. 30, 2013
Inventories Details	'	'
Raw materials	$148,748	$345,049
Finished goods	89,614	444,648
Equipment	11,366	11,366
Inventory, Total	$249,728	$801,063

4_PROPERTY_PLANT_AND_EQUIPMENT2

4. PROPERTY, PLANT AND EQUIPMENT (Details) (USD $)	31-May-14	Nov. 30, 2013
Cost	$9,508,977	'
Accumulated Depreciation	1,452,351	'
Property Plant and Equipment, Net	8,056,626	8,178,694
Sombra site | Land	'	'
Cost	409,134	'
Accumulated Depreciation	0	'
Property Plant and Equipment, Net	409,134	409,134
Sombra site | Building	'	'
Cost	2,944,356	'
Accumulated Depreciation	278,713	'
Property Plant and Equipment, Net	2,665,643	2,702,446
Sombra site | Equipment	'	'
Cost	775,865	'
Accumulated Depreciation	439,032	'
Property Plant and Equipment, Net	336,833	390,465
Sombra site | Equipment - Denami 3000	'	'
Cost	4,254,995	'
Accumulated Depreciation	273,939	'
Property Plant and Equipment, Net	3,981,056	3,975,441
Sombra site | Computer Equipment	'	'
Cost	11,835	'
Accumulated Depreciation	8,827	'
Property Plant and Equipment, Net	3,008	5,918
Sombra site | Vehicle	'	'
Cost	11,622	'
Accumulated Depreciation	872	'
Property Plant and Equipment, Net	10,750	11,331
Mississauga site | Computer Equipment	'	'
Cost	23,464	'
Accumulated Depreciation	22,985	'
Property Plant and Equipment, Net	479	1,316
Mississauga site | Leasehold Improvements	'	'
Cost	102,201	'
Accumulated Depreciation	60,805	'
Property Plant and Equipment, Net	41,396	46,591
Mississauga site | Equipment and fixtures	'	'
Cost	255,463	'
Accumulated Depreciation	191,125	'
Property Plant and Equipment, Net	64,338	77,662
Mississauga site | Equipment - Denami 600	'	'
Cost	720,042	'
Accumulated Depreciation	176,053	'
Property Plant and Equipment, Net	$543,989	$558,390

4_PROPERTY_PLANT_AND_EQUIPMENT3

4. PROPERTY, PLANT AND EQUIPMENT (Details Narrative) (USD $)	3 Months Ended		6 Months Ended
	31-May-14	31-May-13	31-May-14	31-May-13
Property Plant And Equipment Details Narrative	'	'	'	'
Depreciation Expense	$106,317	$117,177	$212,095	$233,593

5_PAYABLE_TO_RELATED_PARTIES_D

5. PAYABLE TO RELATED PARTIES (Details) (USD $)	31-May-14	Nov. 30, 2013
Payable To Related Parties Details	'	'
Michel G. Laporte (shareholder and Director)	$745,750	$719,230
World Asset Management Inc. (reclassified to short-term loans - Note 6, Promissory note (iii))	0	1,495,477
Other loan	0	36,695
Payable to Related Parties, Total	$745,750	$2,251,402

5_PAYABLE_TO_RELATED_PARTIES_D1

5. PAYABLE TO RELATED PARTIES (Details Narrative) (USD $)	3 Months Ended		6 Months Ended
	31-May-14	31-May-13	31-May-14	31-May-13
Payable To Related Parties Details Narrative	'	'	'	'
Interest Expense-Related Party	$13,260	$28,465	$26,250	$60,625

6_SHORTTERM_LOANS_Details

6. SHORT-TERM LOANS (Details) (USD $)	6 Months Ended
	31-May-14
Beginning Balance	$1,961,651
Advances	1,803,182
Interest Accrued	64,103
Repayments	-397,400
Foreign Exchange Adjustments	-37,497
Ending Balance	3,394,039
Term loan (July 2013)	'
Beginning Balance	1,506,560
Advances	0
Interest Accrued	0
Repayments	0
Foreign Exchange Adjustments	-30,880
Ending Balance	1,475,680
Term loan (Dec 2013)	'
Beginning Balance	0
Advances	135,705
Interest Accrued	2,506
Repayments	0
Foreign Exchange Adjustments	2,640
Ending Balance	140,851
Promissory note (i)	'
Beginning Balance	52,533
Advances	0
Interest Accrued	1,600
Repayments	0
Foreign Exchange Adjustments	0
Ending Balance	54,133
Promissory note (ii)	'
Beginning Balance	402,558
Advances	0
Interest Accrued	4,099
Repayments	-397,400
Foreign Exchange Adjustments	-9,257
Ending Balance	0
Promissory note (iii)	'
Beginning Balance	0
Advances	1,667,477
Interest Accrued	55,898
Repayments	0
Foreign Exchange Adjustments	0
Ending Balance	$1,723,375

8_STOCKHOLDERS_EQUITY_Details

8. STOCKHOLDERS' EQUITY (Details) (USD $)	6 Months Ended
	31-May-14
Beginning Balance, Shares	7,231,417
Ending Balance, Shares	11,435,431
December 2013 Private Placement	'
Stock issued	1,081,161
Issued, price per share	2
January 3, 2014 Issuance	'
Stock issued	25,000
Issued, price per share	3.49
January 10, 2014 Issuance	'
Stock issued	50,000
Issued, price per share	2.5
January 17, 2014 Issuance	'
Stock issued	34,688
Issued, price per share	3.69
January 28, 2014 Issuance	'
Stock issued	25,000
Issued, price per share	3.55
March 13, 2014 Conversions	'
Stock issued	21,648
Issued, price per share	2.27
March 17, 2014 Conversions	'
Stock issued	123,528
Issued, price per share	2.25
May 1, 2014 Issuance	'
Stock issued	25,000
Issued, price per share	2.45
May 9, 2014 Conversions	'
Stock issued	10,989
Issued, price per share	2.27
May 9 and 19, 2014 Placement Agent Warrant exercises	'
Stock issued	7,000
Issued, price per share	2
May 27, 2014 Issuance	'
Stock issued	2,500,000
Issued, price per share	2
May 28, 2014 Issuance	'
Stock issued	300,000
Issued, price per share	2

8_STOCKHOLDERS_EQUITY_Details_

8. STOCKHOLDERS' EQUITY (Details 1) (USD $)	6 Months Ended
	31-May-14
Balance beginning of period	2,678,872
Balance end of period	3,923,149
Private Placement Grant Date Dec. 20, 2013	'
Exercise Period	'5 years
Number of Warrants	1,081,161
Exercise Price per share	4
Placement Agent Warrant B Private Placement	'
Exercise Period	'5 years
Number of Warrants	108,116
Exercise Price per share	2
Fair Value of Broker Warrants	257,553
Placement Agent Warrant B Private Placement (November 27, 2013)	'
Exercise Period	'5 years
Number of Warrants	5,000
Exercise Price per share	2
Fair Value of Broker Warrants	6,403
Common Stock Warrant issued-accredited investor Grant Date January 10, 2014	'
Exercise Period	'5 years
Number of Warrants	50,000
Exercise Price per share	4
Placement Agent Warrant exercise	'
Number of Warrants	-7,000
Exercise Price per share	2
Common Stock Warrant issued upon exercise of Placement Agent Warrant	'
Exercise Period Date	'Dec. 20, 2018
Number of Warrants	7,000
Exercise Price per share	4

9_STOCKBASED_COMPENSATION_Deta

9. STOCK-BASED COMPENSATION (Details )	6 Months Ended	12 Months Ended
	31-May-14	Nov. 30, 2013
2008 Option Plan	'	'
Number of Options Outstanding, Beginning	365,931	383,310
Number of Options Granted	0	10,000
Number of Options Exercised	0	0
Number of Options Canceled/Forfeited	-5,215	-27,379
Number of Options, Ending	360,716	365,931
2012 Option Plan	'	'
Number of Options Outstanding, Beginning	100,000	0
Number of Options Granted	0	100,000
Number of Options Exercised	0	0
Number of Options Canceled/Forfeited	0	0
Number of Options, Ending	100,000	100,000

11_COMMITMENTS_Details

11. COMMITMENTS (Details) (USD $)	31-May-14
Mississauga Facility	'
2014	$68,129
2015	136,259
2016	136,259
2017	136,259
2018	11,355
Sombra Facility	'
2014	186,360
2015	369,845
2016	365,820
2017	321,815
2018	$147,250

11_COMMITMENTS_Details_1

11. COMMITMENTS (Details 1)	6 Months Ended
	31-May-14
Agreement 1	'
Start Date	'2013-08-01
End Date	'2018-07-31
Term	'60 months
Agreement 2	'
Start Date	'2013-04-01
End Date	'2018-03-31
Term	'60 months
Agreement 3	'
Start Date	'2013-07-01
End Date	'2018-06-30
Term	'60 months
Agreement 4	'
Start Date	'2011-12-01
End Date	'2016-11-30
Term	'60 months
Agreement 5	'
Start Date	'2012-01-01
End Date	'2016-12-31
Term	'60 months
Agreement 6	'
Start Date	'2012-05-01
End Date	'2015-06-30
Term	'36 months
Agreement 7	'
Start Date	'2013-05-01
End Date	'2018-04-30
Term	'60 months
Agreement 8	'
Start Date	'2013-05-01
End Date	'2018-04-30
Term	'60 months

12_CONTRIBUTION_AGREEMENTS_WIT1

12. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA (Details Narrative) (USD $)	3 Months Ended		6 Months Ended		65 Months Ended
	31-May-14	31-May-13	31-May-14	31-May-13	31-May-14
Mississauga site	'	'	'	'	'
Incentives	$0	$8,559	$0	$10,170	$1,485,285
Sombra site	'	'	'	'	'
Incentives	$25,557	$161,565	$38,592	$168,833	$575,467

13_SEGMENT_INFORMATION_Details

13. SEGMENT INFORMATION (Details) (USD $)	3 Months Ended		6 Months Ended
	31-May-14	31-May-13	31-May-14	31-May-13
Revenue	'	'	'	'
Revenue	$439,405	$2,328,354	$817,883	$2,538,465
United States	'	'	'	'
Revenue	'	'	'	'
Revenue	289,778	2,071,344	570,972	2,171,133
Canada	'	'	'	'
Revenue	'	'	'	'
Revenue	$149,627	$257,010	$246,911	$367,332